Health

Statins are a standard drug for managing high cholesterol, but for patients who need something stronger, a newer class of medicines has become another option. In the more than a …

On April 28, the FDA announced the successful initiation of two real-time clinical trials and released a Request for Information on a broader pilot program for AI-enabled early-phase trials. The …

Over the last decade, public health has gone digital. There are new systems for records, reporting, and analytics. But here’s the reality: tools like electronic health records, lab systems, immunization …

The GLP-1 era is here. The drugs are working. The pounds are coming off. But if we do not get this right, we may inadvertently cause a new sarcopenia epidemic …

Most foot, ankle and lower extremity surgeons have demonstrated success using off-the-shelf implants designed for generalized anatomy. However, as CT imaging, surgical planning software and 3D printed patient-matched implant creation …

There are no FDA-approved treatments for recurrent chronic cough, and a GSK drug from a $2 billion acquisition just lost its chance to become the first one. The drug, camlipixant, …

The war between healthcare providers and payers has increasingly become a battle of algorithms, with AI tools for prior authorizations on one side and AI-powered appeals on the other.  Ashis …

Juno Bio, a women’s health company, announced Thursday that it has secured $3.8 million in funding, which it is using to support the opening of its first women’s health sequencing …

The AMA’s latest National Physician Comparison Report shows aggregate physician burnout falling for the third straight year, down to approximately 41.9% in 2025 from 48.2% in 2023. That’s notable progress, …

The entry story has been told. Goldman Sachs and Charlesbank hold MDVIP. Revelstoke holds a concierge platform. Frontier is building employer-facing DPC infrastructure. Marathon Health and Premise Health are scaling …